1. Gold Standards in Pharmacovigilance

   • Manfred Hauben
   • Jeffrey K. Aronson

   Current Opinion 21 November 2012 Pages: 645 - 655

   

2. Safety Profile of Meropenem

   • Peter Linden

   Review Article 21 November 2012 Pages: 657 - 668

   

3. Physician Response to Patient Reports of Adverse Drug Effects

   • Beatrice A. Golomb
   • John J. McGraw
   • Joel E. Dimsdale

   Short Communication 21 November 2012 Pages: 669 - 675

   

4. Allergic Reactions to Medicines Derived from Pelargonium Species

   • Hugo J. de Boer
   • Ulrich Hagemann
   • Ronald H. B. Meyboom

   Short Communication 21 November 2012 Pages: 677 - 680

   

5. A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler™ in England

   • Michael J. Perrio
   • Lynda V. Wilton
   • Saad A. W. Shakir

   Original Research Article 21 November 2012 Pages: 681 - 695

   

6. Telithromycin Use and Spontaneous Reports of Hepatotoxicity

   • David D. Dore
   • Julia R. DiBello
   • Kate L. Lapane

   Original Research Article 21 November 2012 Pages: 697 - 703

   

7. Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation

   • Catherine B. Johannes
   • Najat Ziyadeh
   • Gerald Faich

   Original Research Article 21 November 2012 Pages: 705 - 713

   

8. Criteria Revision and Performance Comparison of Three Methods of Signal Detection Applied to the Spontaneous Reporting Database of a Pharmaceutical Manufacturer

   • Yasuyuki Matsushita
   • Yasufumi Kuroda
   • Isao Yoshimura

   Original Research Article 21 November 2012 Pages: 715 - 726

   

9. Drug-Induced Endocrine and Metabolic Disorders

   • Chaker Ben Salem
   • Raoudha Slim
   • Kamel Bouraoui

   Correspondence 21 November 2012 Pages: 727 - 728

10. The Authors’ Reply

    • Ronald C. W. Ma
    • Alice P. S. Kong
    • Juliana C. N. Chan

    Correspondence 21 November 2012 Pages: 728 - 729